Former FDA commissioner joins J&J board
This article was originally published in Scrip
Executive Summary
Johnson and Johnson has appointed Dr Mark B McClellan to its board of directors – effective 15 October 2013. He will serve on the regulatory, compliance and government affairs committee, and the science, technology and sustainability committee. Prior to joining the New Brunswick, New Jersey-headquartered firm, Dr McClellan was commissioner of the US FDA from 2002-2004 and administrator the Centers for Medicare and Medicaid services, a department of US Health and Human Services, from 2004-2006. Currently, Dr McClellan is senior fellow in economic studies, and director of the initiative on value and innovation in healthcare at Brookings Institution.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.